Luly Jay R. has been a registered insider since 2003.
As Chief Executive Officer at Enanta Pharmaceuticals, Luly Jay R. last made a transaction on 2/12/2025.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 8 |
63% |
2% |
1% |
132 |
1 Year |
8 |
0% |
-- |
-- |
-- |
| 8 |
50% |
0% |
3% |
103 |
9 Month |
8 |
0% |
-- |
-- |
-- |
| 8 |
38% |
1% |
-6% |
86 |
6 Month |
8 |
0% |
-- |
-- |
-- |
| 8 |
38% |
-2% |
-2% |
47 |
3 Month |
8 |
0% |
-- |
-- |
-- |
| 9 |
67% |
9% |
10% |
37 |
1 Month |
9 |
0% |
-- |
-- |
-- |
| 9 |
78% |
8% |
3% |
47 |
1 Week |
9 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 14 |
93% |
-20% |
-18% |
154 |
1 Year |
14 |
0% |
-- |
-- |
-- |
| 14 |
57% |
-7% |
-5% |
125 |
9 Month |
14 |
0% |
-- |
-- |
-- |
| 14 |
43% |
-5% |
3% |
119 |
6 Month |
14 |
0% |
-- |
-- |
-- |
| 15 |
53% |
-0% |
-6% |
110 |
3 Month |
15 |
0% |
-- |
-- |
-- |
| 15 |
47% |
-1% |
4% |
59 |
1 Month |
15 |
0% |
-- |
-- |
-- |
| 15 |
60% |
-2% |
-0% |
41 |
1 Week |
15 |
0% |
-- |
-- |
-- |
| Scorecards Updated 3/27/2025 10:21 AM EST |
Latest Transaction Date: |
2/12/2025 |
| Average days between Transaction and Entered Dates: |
2 |
